Connective tissue diseases in primary biliary cirrhosis: A population-based cohort study

被引:48
|
作者
Wang, Li [1 ,2 ]
Zhang, Feng-Chun [1 ,2 ]
Chen, Hua [1 ,2 ]
Zhang, Xuan [1 ,2 ]
Xu, Dong [1 ,2 ]
Li, Yong-Zhe [1 ,2 ]
Wang, Qian [1 ,2 ]
Gao, Li-Xia [3 ]
Yang, Yun-Jiao [1 ,2 ]
Kong, Fang [1 ,2 ]
Wang, Ke [2 ,4 ,5 ]
机构
[1] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Rheumatol & Clin Immunol, Key Lab Rheumatol & Clin Immunol,Minist Educ, Beijing 100005, Peoples R China
[2] Peking Union Med Coll, Beijing 100005, Peoples R China
[3] Hebei Med Univ, Hosp 2, Dept Rheumatol, Shijiazhuang 050000, Hebei Province, Peoples R China
[4] Chinese Acad Med Sci, Inst Basic Med Sci, Beijing 100005, Peoples R China
[5] Chinese Acad Med Sci, Sch Basic Med, Beijing 100005, Peoples R China
关键词
Cirrhosis; Biliary; Connective tissue disease; Sjogren's syndrome; Systemic sclerosis; Raynaud phenomenon; INTERSTITIAL LUNG-DISEASE; LONG-TERM PROGNOSIS; SJOGRENS-SYNDROME; CLASSIFICATION CRITERIA; AMERICAN-COLLEGE; URSODEOXYCHOLIC ACID; BIOCHEMICAL RESPONSE; CLINICAL-FEATURES; REVISED CRITERIA; POLYMYOSITIS;
D O I
10.3748/wjg.v19.i31.5131
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: To establish the frequency and clinical features of connective tissue diseases (CTDs) in a cohort of Chinese patients with primary biliary cirrhosis (PBC). METHODS: Three-hundred and twenty-two Chinese PBC patients were screened for the presence of CTD, and the systemic involvement was assessed. The differences in clinical features and laboratory findings between PBC patients with and without CTD were documented. The diversity of incidence of CTDs in PBC of different countries and areas was discussed. For the comparison of normally distributed data, Student' s t test was used, while non-parametric test (Wilcoxon test) for the non-normally distributed data and 2 x 2 chi(2) or Fisher's exact tests for the ratio. RESULTS: One-hundred and fifty (46.6%) PBC patients had one or more CTDs. The most common CTD was Sjogren's syndrome (SS, 121 cases, 36.2%). There were nine cases of systemic sclerosis (SSc, 2.8%), 12 of systemic lupus erythematosus (SLE, 3.7%), nine of rheumatoid arthritis (RA, 2.8%), and 10 of polymyositis (PM, 3.1%) in this cohort. Compared to patients with PBC only, the PBC + SS patients were more likely to have fever and elevated erythrocyte sedimentation rate (ESR), higher serum immunoglobulin G (IgG) levels and more frequent rheumatoid factor (RF) and interstitial lung disease (ILD) incidences; PBC + SSc patients had higher frequency of ILD; PBC + SLE patients had lower white blood cell (WBC) count, hemoglobin (Hb), platelet count,gamma-glutamyl transpeptidase and immunoglobulin M levels, but higher frequency of renal involvement; PBC + RA patients had lower Hb, higher serum IgG, alkaline phosphatase, faster ESR and a higher ratio of RF positivity; PBC + PM patients had higher WBC count and a tendency towards myocardial involvement. CONCLUSION: Besides the common liver manifestation of PBC, systemic involvement and overlaps with other CTDs are not infrequent in Chinese patients. When overlapping with other CTDs, PBC patients manifested some special clinical and laboratory features which may have effect on the prognosis.
引用
收藏
页码:5131 / 5137
页数:7
相关论文
共 50 条
  • [31] The incidence of primary biliary cirrhosis (PBC) is rising: A Canadian population-based study from 1996 to 2002
    Myers, Robert P.
    Fong, Andrew A.
    Swain, Mark G.
    Quan, Hude
    HEPATOLOGY, 2006, 44 (04) : 635A - 635A
  • [32] A population-based study of HLA class II polymorphism in Swedish patients with primary biliary cirrhosis.
    Lindgren, S
    Wassmuth, R
    Deppner, F
    Danielsson, Å
    Hultcrantz, R
    Lööf, L
    Olson, R
    Prytz, H
    Sandberg-gertzen, H
    Wallerstedt, S
    HEPATOLOGY, 1998, 28 (04) : 540A - 540A
  • [33] Incidence of hepatic outcomes in patients with cirrhosis due to primary biliary cholangitis: A population-based epidemiology study
    Titievsky, Lina
    Ness, Erik
    Law, Amy
    Goldman, Ellie
    Wheeler, Darren
    Bertoia, Monica
    Seeger, John D.
    Nguyen, Mindie
    Patel, Yuval
    Adekunle, Femi
    Bassanelli, Chiara
    JOURNAL OF HEPATOLOGY, 2021, 75 : S434 - S434
  • [34] Acute exacerbations of fibrosing interstitial lung disease associated with connective tissue diseases: a population-based study
    Mengshu Cao
    Jian Sheng
    Xiaohua Qiu
    Dandan Wang
    Dongmei Wang
    Yang Wang
    Yonglong Xiao
    Hourong Cai
    BMC Pulmonary Medicine, 19
  • [35] Acute exacerbations of fibrosing interstitial lung disease associated with connective tissue diseases: a population-based study
    Cao, Mengshu
    Sheng, Jian
    Qiu, Xiaohua
    Wang, Dandan
    Wang, Dongmei
    Wang, Yang
    Xiao, Yonglong
    Cai, Hourong
    BMC PULMONARY MEDICINE, 2019, 19 (01)
  • [36] Incidence, etiology and mortality of cirrhosis: a population-based cohort study
    Fialla, Annette Dam
    de Muckadell, Ove B. Schaffalitzky
    Lassen, Annmarie Touborg
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2012, 47 (06) : 702 - 709
  • [37] Smoking and risk of liver cirrhosis: a population-based cohort study
    Dam, Marie Kamstrup
    Flensborg-Madsen, Trine
    Eliasen, Marie
    Becker, Ulrik
    Tolstrup, Janne Schurmann
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2013, 48 (05) : 585 - 591
  • [38] Autoimmune Connective Tissue Disease Following Carbon Monoxide Poisoning: A Nationwide Population-Based Cohort Study
    Huang, Chien-Cheng
    Ho, Chung-Han
    Chen, Yi-Chen
    Hsu, Chien-Chin
    Lin, Hung-Jung
    Wang, Jhi-Joung
    Guo, How-Ran
    CLINICAL EPIDEMIOLOGY, 2020, 12 : 1287 - 1298
  • [39] IgA and IgG tissue transglutaminase antibody prevalence and clinical significance in connective tissue diseases, inflammatory bowel disease, and primary biliary cirrhosis
    Bizzaro, N
    Villalta, D
    Tonutti, E
    Doria, A
    Tampoia, M
    Bassetti, D
    Tozzoli, R
    DIGESTIVE DISEASES AND SCIENCES, 2003, 48 (12) : 2360 - 2365
  • [40] IgA and IgG Tissue Transglutaminase Antibody Prevalence and Clinical Significance in Connective Tissue Diseases, Inflammatory Bowel Disease, and Primary Biliary Cirrhosis
    N. Bizzaro
    D. Villalta
    E. Tonutti
    A. Doria
    M. Tampoia
    D. Bassetti
    R. Tozzoli
    Digestive Diseases and Sciences, 2003, 48 : 2360 - 2365